These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharmacological and clinical observations on the combination of scopolamine N-butylbromide and aminopyrine sodium sulfonate (buscopan compositum)]. MARINO A; MURARO U Rass Int Clin Ter; 1959 Dec; 39():1247-93 contd. PubMed ID: 14421165 [No Abstract] [Full Text] [Related]
3. [Studies on the pharmacologic effect and clinical use of hyoscine-N-butylbromide (buscopan)]. HEINKEL K Dtsch Z Verdau Stoffwechselkr; 1951 Jul; 11(4):180-95. PubMed ID: 14872696 [No Abstract] [Full Text] [Related]
4. [Post-anesthetic vomiting; the results of treatment with scopolamine-N-butylbromide (buscopan) and promethazine (fargan)]. REVERBERI S; BOZZA ML Minerva Anestesiol; 1955 Sep; 21(9):205-12. PubMed ID: 13279605 [No Abstract] [Full Text] [Related]
5. Atropine as an antisialogogue, compared with l-hyoscyamine (bellafoline), scopolamine butylbromide (buscopan) and oxyphenonium (antrenyl). DIAMANT H; FEINMESSER M Br J Anaesth; 1959 May; 31(5):205-9. PubMed ID: 13662482 [No Abstract] [Full Text] [Related]
7. [The treatment of spastic states with hyoscine-N-butylbromide]. HARTMANN HG Z Arztl Fortbild (Jena); 1953 Aug; 47(15):541-3. PubMed ID: 13090960 [No Abstract] [Full Text] [Related]
8. [Comparative studies on the effect of bile acids and scopolamine-N-butylbromide on intestinal motoricity]. BERGMANN M Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 223(4):311-3. PubMed ID: 13223807 [No Abstract] [Full Text] [Related]
9. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants]. GADEKE R Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076 [No Abstract] [Full Text] [Related]
10. Routine use of hyoscine N butylbromide (Buscopan) in double contrast barium enema examinations. Lee JR Clin Radiol; 1982 May; 33(3):273-6. PubMed ID: 7075130 [TBL] [Abstract][Full Text] [Related]
11. Hyoscine-N-butylbromide (Buscopan) as a duodenal relaxant in tubeless duodenography. Ayre-Smith G Acta Radiol Diagn (Stockh); 1976 Sep; 17(5B):701-13. PubMed ID: 790897 [TBL] [Abstract][Full Text] [Related]
12. Response to Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later. Campbell ML J Pain Symptom Manage; 2019 Jan; 57(1):e14-e15. PubMed ID: 30248383 [No Abstract] [Full Text] [Related]
13. Letter to the Editor Re: "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later". Clark K; Sheehan C; Currow DC J Pain Symptom Manage; 2019 Jan; 57(1):e16-e17. PubMed ID: 30367928 [No Abstract] [Full Text] [Related]
14. Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later". Boland JW; Currow D; Johnson M J Pain Symptom Manage; 2019 Mar; 57(3):e12-e13. PubMed ID: 30496789 [No Abstract] [Full Text] [Related]
15. Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later". van Esch HJ; Geijteman ECT; van der Rijt CCD J Pain Symptom Manage; 2019 Apr; 57(4):e1-e2. PubMed ID: 30660674 [No Abstract] [Full Text] [Related]
16. [Cardiovascular action of butyl-escopolamonio (Buscopan)]. CICARDO VH; VON DER BECKE AO Rev Soc Argent Biol; 1955; 31(7-8):277-82. PubMed ID: 13323639 [No Abstract] [Full Text] [Related]
18. [Study of hyoscine N-butyl bromide during labor]. GUIAVARC'H R Sem Hop Ther Paris; 1960 May; 36():442-7. PubMed ID: 13830116 [No Abstract] [Full Text] [Related]
19. Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life. Abe A; Amano K; Ishiki H JAMA; 2022 Jan; 327(3):285. PubMed ID: 35040894 [No Abstract] [Full Text] [Related]
20. Prophylactic scopolamine butylbromide reduced death rattle in patients in the dying phase. Mechineni A Ann Intern Med; 2022 Mar; 175(3):JC31. PubMed ID: 35226526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]